摘要:
The present invention provides a small-molecule inhibitor targeting an EB virus nuclear antigen protein, and/or a pharmaceutical composition containing the same, which can be used for the treatment of a disease caused by EBNA1 activity, such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The present invention further provides a small-molecule inhibitor targeting an EB virus nuclear antigen protein, and/or a pharmaceutical composition containing the same, which can be used for the treatment of a disease caused by EBV infection in a lytic and/or latent phase.
摘要:
Personal care compositions, such as oral care and skin care compositions containing a flavor/perfume system comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers.
摘要:
The invention provides EBNA1 inhibitors, and pharmaceutical compositions comprising the same, that are useful for the treatment of diseases caused by EBNA1 activity such as, but not limited to, cancer, infectious mononucleosis, chronic fatigue syndrome, multiple sclerosis, systemic lupus erythematosus and/or rheumatoid arthritis. The compounds and compositions of the invention are further useful for the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection. The compounds and compositions of the invention are further useful for the treatment of diseases caused by lytic EBV infection.
摘要:
A process for producing quinazolin-4-one or a derivative thereof which comprises reacting anthranilic acid or a derivative thereof with formic acid or a derivative thereof in the presence of ammonia or reacting ammonium anthranilate or a derivative thereof with formic acid or a derivative thereof.
摘要:
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; catalyst comprises a copper atom or ion, and a ligand; base represents a Bronsted base; and R represents optionally substituted alkyl, cycloalkyl, aralkyl, heteroaralkyl, alkenylalkyl, or alkynylalkyl.
摘要:
Fluorierte aromatische Nitroverbindungen werden zu fluorierten aromatischen Aminen katalytisch hydriert, indem man die Hydrierung in flüssiger Phase und in Gegenwart eines Katalysators enthaltend wenigstens ein Metall oder eine Metallverbindung aus der Gruppe Nickel, Kobalt und den Edelmetallen und in Gegenwart mindestens einer Schwefelverbindung der Formel R¹-S(O) n -R² durchführt. So erhaltene fluorierte aromatische Amine sind besonders rein und enthalten besonders wenig defluorierte Produkte.